Diffuse alveolar haemorrhage in ANCA-associated vasculitis

Area of Science:

• Pulmonology
• Rheumatology
• Nephrology

Background:

• Diffuse alveolar haemorrhage (DAH) is a severe complication of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).
• DAH in AAV is rare but carries significant morbidity and mortality.
• Concurrent renal disease is frequently observed, exacerbating patient outcomes.

Purpose of the Study:

• To review the diagnostic features, treatment strategies, and outcomes of DAH in AAV.
• To synthesize current knowledge on managing this serious condition.
• To highlight areas for future research in optimizing therapeutic regimens.

Main Methods:

• Literature review of diagnostic features, treatment, and outcomes for DAH in AAV.
• Analysis of diagnostic modalities including imaging (chest radiography, HRCT) and lung function tests (inhaled carbon monoxide uptake).
• Evaluation of treatment approaches (glucocorticoids, cyclophosphamide, azathioprine) and the role of plasmapheresis.

Main Results:

• Common symptoms include haemoptysis and dyspnoea, though non-specific.
• High-resolution computed tomography (HRCT) is more sensitive than chest radiography for diagnosis.
• Lung function tests showing increased inhaled carbon monoxide uptake and reduced C(15)O clearance suggest intra-alveolar bleeding. Fiberoptic bronchoscopy with bronchoalveolar lavage aids in detecting super-added infections.

Conclusions:

• DAH in AAV requires a multi-faceted diagnostic approach.
• Individualized treatment based on immunosuppression (glucocorticoids, cyclophosphamide, azathioprine) is crucial.
• Further research is needed to establish optimal, low-side-effect treatment protocols and clarify the role of plasmapheresis.